2016 Jan 11
Batting it out of the park
Ph.D. student Katie Gayvert's "Moneyball" approach to cancer involves a computational model to screen for drugs that are too toxic to tolerate. Read more
2016 Jan 06
Eli Lilly, Pfizer, J&J, AbbVie join $48M bet on NYC cancer drug startup
Director Lewis Cantley, Ph.D., is heading a new pharmaceutical venture. Read more
2016 Jan 04
30 Under 30
Graduate students Kaitlyn Gayvert and Neel Madhukar were named to prestigious Forbes list Read more
2015 Dec 29
Glembatumumab vedotin as a treatment in Triple Negative Breast Cancer
Linda Vahdat, M.D., discusses the antibody drug conjugate glembatumumab vedotin in the treatment of women with triple negative breast cancer. Read more
2015 Dec 23
CLL Research Highlights From ASH 2015
Richard Furman, M.D., gives a rundown of research and treatment advances for chronic lymphocytic leukemia Read more
2015 Dec 22
Immune checkpoint inhibition an ‘important new frontier’ in lymphoma
John P. Leonard, M.D., discusses immune checkpoint inhibitors at the Lymphoma & Myeloma 2015 conference. Read more
2015 Dec 17
Comparing therapies for Hodgkin's lymphoma in varied populations
Peter Martin, M.D., comments on studies comparing therapies for Hodgkin's lymphoma. Read more
2015 Dec 15
New horizons for interferon therapy in MPNs
Richard Silver, M.D., discusses interferon therapy for the treatment of myeloproliferative neoplasms. Read more
2015 Dec 15
Emerging strategies for treating progressive indolent B-Cell NHL
John P. Leonard, M.D., presented on indolent B-Cell NHL treatment at the recent Chemotherapy Foundation Symposium. Read more
2015 Dec 15
Phase II trial tests efficacy of glembatumumab for triple negative breast cancer
Linda Vahdat, M.D., discusses the METRIC trial of antibody-drug conjugate glembatumumab vedotin. Read more
2015 Dec 14
Posthumous honor for hematology legend Aaron Marcus
Aaron J. Marcus, M.D., was recently recognized at the ASH Annual Meeting with the 2015 Wallace H. Coulter Award for Lifetime Achievement in Hematology. Read more
2015 Dec 14
Ibrutinib ‘new standard’ for relapsed, refractory mantle cell lymphoma
Peter Martin, comments on phase III trial findings about ibrutinib therapy for relapsed or refractory mantle cell lymphoma. Read more
2015 Dec 14
Lung inflammation contributes to metastasis
Pre-existing inflammation in the lungs may increase the risk that cancers beginning elsewhere will spread to the organ, according to Vivek Mittal, Ph.D., and colleagues. Read more
2015 Dec 14
Amid cancer breakthroughs, hospitals aim for top talent, clinical trials
Dean Laurie Glimcher, M.D., discusses recent big-name cancer recruits at Weill Cornell Medicine. Read more
2015 Dec 11
Surgery in the Aging Patient
Heather Yeo, M.D., MPH, discusses care management for geriatric patients and their caregivers. Read more
2015 Dec 10
Leonard lists his lymphoma highlights
Several trade publications turned to John Leonard, M.D., for his insights into the highlights of the ASH Annual Meeting Read more
2015 Dec 09
How cryotherapy prevents hair loss from chemo
Tessa Cigler, M.D., discusses the use of cool caps during breast cancer treatment. Read more
2015 Dec 02
Modified chemotherapy regimen effective, less toxic for gastric cancers
Manish Shah, M.D., reports on a phase II study about a modified first-line chemo regimen for advanced gastric cancer. Read more
2015 Dec 02
High-End Cancer Treatment for Pets
Kristy Richards, M.D., Ph.D., discusses how cancer research on dogs can benefit humans Read more
